136 related articles for article (PubMed ID: 32132429)
1. Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies.
Quarti Trevano F; Dell'Oro R; Biffi A; Seravalle G; Corrao G; Mancia G; Grassi G
J Hypertens; 2020 Apr; 38(4):565-572. PubMed ID: 32132429
[TBL] [Abstract][Full Text] [Related]
2. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic Neural Overdrive in the Obese and Overweight State.
Grassi G; Biffi A; Seravalle G; Trevano FQ; Dell'Oro R; Corrao G; Mancia G
Hypertension; 2019 Aug; 74(2):349-358. PubMed ID: 31203727
[TBL] [Abstract][Full Text] [Related]
4. Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis.
Quarti-Trevano F; Biffi A; Bonzani M; Seravalle G; Corrao G; Mancia G; Grassi G
J Hypertens; 2021 Nov; 39(11):2281-2289. PubMed ID: 34620811
[TBL] [Abstract][Full Text] [Related]
5. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome.
Seravalle G; Vanoli J; Molisano C; Merati V; Grassi G
Acta Diabetol; 2022 Nov; 59(11):1429-1435. PubMed ID: 35904642
[TBL] [Abstract][Full Text] [Related]
6. Neuroadrenergic activation in obstructive sleep apnoea syndrome: a new selected meta-analysis - revisited.
Biffi A; Quarti-Trevano F; Bonzani M; Seravalle G; Corrao G; Mancia G; Grassi G
J Hypertens; 2022 Jan; 40(1):15-23. PubMed ID: 34857700
[TBL] [Abstract][Full Text] [Related]
7. Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea.
Grassi G; Seravalle G; Quarti-Trevano F; Mineo C; Lonati L; Facchetti R; Mancia G
J Hypertens; 2010 Jun; 28(6):1313-20. PubMed ID: 20164804
[TBL] [Abstract][Full Text] [Related]
8. An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans.
Swierblewska E; Hering D; Kara T; Kunicka K; Kruszewski P; Bieniaszewski L; Boutouyrie P; Somers VK; Narkiewicz K
J Hypertens; 2010 May; 28(5):979-84. PubMed ID: 20408258
[TBL] [Abstract][Full Text] [Related]
9. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives.
Grassi G; Dell'Oro R; Facchini A; Quarti Trevano F; Bolla GB; Mancia G
J Hypertens; 2004 Dec; 22(12):2363-9. PubMed ID: 15614031
[TBL] [Abstract][Full Text] [Related]
10. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
[TBL] [Abstract][Full Text] [Related]
11. Time delay of baroreflex control and oscillatory pattern of sympathetic activity in patients with metabolic syndrome and obstructive sleep apnea.
Toschi-Dias E; Trombetta IC; Dias da Silva VJ; Maki-Nunes C; Cepeda FX; Alves MJ; Drager LF; Lorenzi-Filho G; Negrao CE; Rondon MU
Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H1038-44. PubMed ID: 23355343
[TBL] [Abstract][Full Text] [Related]
12. Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea.
Grassi G; Seravalle G; Brambilla G; Buzzi S; Volpe M; Cesana F; Dell'oro R; Mancia G
J Hypertens; 2014 Feb; 32(2):383-8. PubMed ID: 24419212
[TBL] [Abstract][Full Text] [Related]
13. Heart rate as a sympathetic marker during acute adrenergic challenge.
Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
[TBL] [Abstract][Full Text] [Related]
14. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension.
Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G
Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis.
Grassi G; D'Arrigo G; Pisano A; Bolignano D; Mallamaci F; Dell'Oro R; Quarti-Trevano F; Seravalle G; Mancia G; Zoccali C
J Hypertens; 2019 Sep; 37(9):1746-1756. PubMed ID: 30950979
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis.
Grassi G; Biffi A; Dell'Oro R; Quarti Trevano F; Seravalle G; Corrao G; Perseghin G; Mancia G
J Hypertens; 2020 Aug; 38(8):1436-1442. PubMed ID: 32371764
[TBL] [Abstract][Full Text] [Related]
17. Limited reliability of heart rate as a sympathetic marker in chronic kidney disease.
Dell'Oro R; Quarti-Trevano F; Seravalle G; Bertoli S; Lovati C; Mancia G; Grassi G
J Hypertens; 2021 Jul; 39(7):1429-1434. PubMed ID: 33394867
[TBL] [Abstract][Full Text] [Related]
18. Resting sympathetic outflow does not predict the morning blood pressure surge in hypertension.
Hering D; Kucharska W; Kara T; Somers VK; Narkiewicz K
J Hypertens; 2011 Dec; 29(12):2381-6. PubMed ID: 21986622
[TBL] [Abstract][Full Text] [Related]
19. Arterial baroreflex regulation of muscle sympathetic nerve activity at rest and during stress.
Incognito AV; Duplea SG; Lee JB; Sussman J; Shepherd AD; Doherty CJ; Cacoilo JA; Notay K; Millar PJ
J Physiol; 2019 Sep; 597(18):4729-4741. PubMed ID: 31368530
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity.
Grassi G; Seravalle G; Dell'Oro R; Arenare F; Facchetti R; Mancia G
Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):469-75. PubMed ID: 19157817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
